RESMED INC — Director's Dealing 2020

Nov 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-20

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-20	ResMed Common Stock	M	1176	$84.98	Acquired	145181	Direct
2020-11-23	ResMed Common Stock	G	10000	—	Disposed	135181	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-20	ResMed Common Stock Options	$84.98	M	1176	Disposed	2024-11-16	ResMed Common Stock (1176)	Direct

Footnotes

F1: Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.

F2: Represents date options first became exercisable. Options vest 1/3 per year.